JPH05137785A - Balloon infuser - Google Patents

Balloon infuser

Info

Publication number
JPH05137785A
JPH05137785A JP3328102A JP32810291A JPH05137785A JP H05137785 A JPH05137785 A JP H05137785A JP 3328102 A JP3328102 A JP 3328102A JP 32810291 A JP32810291 A JP 32810291A JP H05137785 A JPH05137785 A JP H05137785A
Authority
JP
Japan
Prior art keywords
balloon
chemical liquid
tube
flow rate
rate control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3328102A
Other languages
Japanese (ja)
Other versions
JP3109192B2 (en
Inventor
Norihiro Hiejima
徳寛 比恵島
Hajime Tsujikawa
肇 辻川
Hiroshi Fukushima
浩 福島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissho Corp
Original Assignee
Nissho Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissho Corp filed Critical Nissho Corp
Priority to JP03328102A priority Critical patent/JP3109192B2/en
Publication of JPH05137785A publication Critical patent/JPH05137785A/en
Application granted granted Critical
Publication of JP3109192B2 publication Critical patent/JP3109192B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To decrease the grades of balloon infusers by providing a liquid drug flow rate control section between a communicating pipe and the front end of a tube or within the tube at the front end of the tube. CONSTITUTION:The liquid drug flow rate control section 31 which is closed at the front end on a downstream side and is formed of a pipe, etc., having one piece of fine hole is connected between the front end 40 of the tube 32 and the communicating pipe 34 by a connector 30. The flow rate control section 31, the tube 32 and the connector 30 are thermally welded and connected by a sheath part 41 having the inside diameter larger than the outside diameters of the flow rate control section 31 and the tube 32 in such a case. The flow rate control section 31 is otherwise disposed within the tube 30 at the front end 40 of the tube 32. The front end 40 of the tube 32 is thermally welded and molded into the connector 30 in such a case. Further, a filter 42 for removing micromaterials contained in the liquid drug in the balloon 3 may be provided between the pipe 34 and section 31. The flow rate of the flow rate control section 31 is controlled to 20ml/hour.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は所定量の薬液を体内に、
注入するためのバル−ンインフュ−ザ−に関し、更に詳
しくは、バル−ン内に加圧状態で貯蔵した薬液を、一定
速度で短時間に患者に注入することができるバル−ンイ
ンフュ−ザ−に関する。
BACKGROUND OF THE INVENTION The present invention provides a predetermined amount of drug solution in the body,
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a balloon infuser for injecting, and more particularly, to a balloon infuser capable of injecting a drug solution stored under pressure in a balloon into a patient at a constant speed in a short time. ..

【0002】[0002]

【従来の技術】従来より、抗生物質、抗ガン剤、麻酔剤
等の薬液を血管、膀胱等に少しずつ注入する手段とし
て、弾性材料からなるバル−ンに薬液を収納し、バル−
ンの収縮力を利用して薬液を長時間にわたって人体に持
続注入する器具(特開平2-11160号公報)が知られてい
る。該公報に記載されているバル−ンインヒュ−ザ−
は、バル−ンを収納するバル−ン部と、微細孔パイプか
らなる流量制御部を有するチュ−ブを主体とする薬液流
出アセンブリとからなり、バル−ン部の薬液注入流出部
に設けられた栓体に薬液流出アセンブリの端部に設けた
薬液注入針を刺しこんでバル−ン内の薬液を流出したり
している。
2. Description of the Related Art Conventionally, as a means for gradually injecting a drug solution such as an antibiotic, an anti-cancer agent or an anesthetic into a blood vessel, a bladder, etc., the drug solution is stored in a balloon made of an elastic material.
There is known a device (Japanese Patent Application Laid-Open No. 2-11160) for continuously injecting a liquid medicine into a human body for a long time by utilizing the contracting force of the liquid. The balloon intruder described in the publication.
Includes a balloon part for accommodating the balun and a chemical liquid outflow assembly mainly having a tube having a flow rate control part composed of a fine hole pipe, and provided in the chemical liquid inflow / outflow part of the balun part. The liquid medicine in the balloon is flown out by piercing the stopper with a liquid medicine injection needle provided at the end of the liquid medicine outflow assembly.

【0003】バル−ンインヒュ−ザ−の使用に際して
は、まず注射器の注射針を栓体に刺しこんでバル−ン内
に薬液を注入し、所定量の薬液の充填が終わると注射針
を栓体から抜きとる。次いで薬液流出アセンブリの端部
に設けた薬液注入針を該栓体に刺しこんでバル−ン内の
薬液を患者の体内に注入する。しかしこのバル−ンイン
ヒュ−ザ−は栓体への針の刺しこみ方によって針外面か
ら薬液が洩れる欠点がある。更に、このバル−ンインヒ
ュ−ザ−はバル−ンの内部に設けたバル−ンの支持軸で
ある外軸の一端より薬液を流出させているので外軸内部
と内軸外面との間にクリアランスがあり、バル−ンが完
全に収縮してもある程度の薬液がどうしても外軸内に残
ってしまうことがあり、薬液が塩酸モルヒネ、抗ガン剤
等のように高価な場合には残液が多いことは経済的に大
きな問題である。
In using the balloon injector, first, the injection needle of a syringe is inserted into the stopper to inject the liquid medicine into the balloon, and when the prescribed amount of the liquid medicine is filled, the needle is closed. Remove from Then, a drug solution injection needle provided at the end of the drug solution outflow assembly is inserted into the stopper to inject the drug solution in the balloon into the patient's body. However, this balloon inuser has a drawback that the liquid medicine leaks from the outer surface of the needle depending on how the needle is inserted into the stopper. Further, this balloon intruder causes the chemical solution to flow out from one end of the outer shaft, which is the support shaft of the balloon provided inside the balloon, so that there is a clearance between the inside of the outer shaft and the outer surface of the inner shaft. However, even if the balloon is completely contracted, a certain amount of drug solution may inevitably remain in the outer shaft, and if the drug solution is expensive such as morphine hydrochloride and anti-cancer drug, there is a lot of residual solution. That is a big financial problem.

【0004】本発明者等はこれらの欠点を解決したバル
−ンインヒュ−ザ−として、図11および図12に示すバル
−ンインヒュ−ザ−を発明し特許出願(特願平第2−21
6621号)した。図11は該バル−ンインヒュ−ザ−の全体
説明図であって、連通パイプがハウジングの接続具に嵌
合または螺合していない状態を示しており、図12は図11
に示すハウジングのバル−ンに薬液を充填した時の状態
を示す拡大断面図である。図11および図12のバル−ンイ
ンヒュ−ザ−は、バル−ン46を収納するハウジング47か
らなるバル−ン部cと、薬液の流量を調節するための流
量制御部48を有する薬液流出アセンブリdとからなって
いる。バル−ン46は図12に示す棒状内軸50と、該内軸50
に滑動自在に外装されてなる円筒状外軸51と、前記内軸
50の一端であって外軸51が外装される側と反対側の端部
に内軸と一体に形成された内軸受け52と、前記内軸50お
よび外軸51を被覆するようにこれら両軸の外部に設けら
れ、その一端が内軸50に密着固定され、他端が外軸51に
密着固定された弾性材料製バル−ン46とからなってい
る。またハウジング47の一端には薬液出入部であるアダ
プタ−53が形成され、内軸受け52内部を介して薬液通路
54と連通している。薬液通路54内には、バル−ン46内部
への薬液注入時にバル−ン内の薬液が流出するのを阻止
し、バル−ン46からの薬液流出時には前記薬液通路54の
開放側端部から薬液流出アセンブリdの端部に設けられ
た連通パイプ55が挿入されて、弁が開口する逆止弁56が
設けられた構造をしている。
The inventors of the present invention have invented a balloon fuser shown in FIG. 11 and FIG. 12 as a balloon fuser which solves these drawbacks and applied for a patent (Japanese Patent Application No. 2-21).
No. 6621). FIG. 11 is an overall explanatory view of the balloon inuser, showing a state in which the communication pipe is not fitted or screwed into the connector of the housing, and FIG. 12 is shown in FIG.
FIG. 9 is an enlarged cross-sectional view showing a state when the balloon of the housing shown in FIG. The balloon intruder of FIGS. 11 and 12 is a chemical liquid outflow assembly d having a balloon portion c formed of a housing 47 for accommodating the balloon 46 and a flow rate control portion 48 for adjusting the flow rate of the chemical liquid. It consists of The balloon 46 includes a rod-shaped inner shaft 50 shown in FIG.
A cylindrical outer shaft 51 slidably mounted on the inner shaft, and the inner shaft.
An inner bearing 52 integrally formed with the inner shaft at one end of the outer shaft 51 opposite to the outer shaft 51, and both shafts so as to cover the inner shaft 50 and the outer shaft 51. A ball 46 made of an elastic material, which is provided outside and has one end closely fixed to the inner shaft 50 and the other end closely fixed to the outer shaft 51. An adapter 53, which is a chemical liquid inlet / outlet portion, is formed at one end of the housing 47, and a chemical liquid passage is formed through the inside of the inner bearing 52.
It communicates with 54. In the chemical liquid passage 54, when the chemical liquid is injected into the balloon 46, the chemical liquid in the balloon is prevented from flowing out, and when the chemical liquid is discharged from the balloon 46, the chemical liquid passage 54 is opened from the open end. A communication pipe 55 provided at the end of the chemical liquid outflow assembly d is inserted, and a check valve 56 having a valve opening is provided.

【0005】[0005]

【発明が解決しょうとする課題】しかしながら、かかる
バル−ンインヒュ−ザ−の使用に際しては薬液の流量を
調節するための流量制御部48は、静脈針等を接続する接
続具57と患者の腕に絆創膏等で固着されて患者の体内に
薬液の注入が行われるので、薬液の流速が患者の体温に
よって影響を受ける問題がある。そして患者の腕の体温
は、個人差およびその時の患者の状態によって32℃〜40
℃まで異なるので所望する時間で薬液を患者の体内に供
給するように調節したバル−ンインヒュ−ザ−を製造す
るには、その状態に応じた多くの品種のバル−ンインヒ
ュ−ザ−を予め準備しなければならない問題がある。
However, when using such a balloon-in-user, the flow rate control unit 48 for adjusting the flow rate of the drug solution is provided in the connection tool 57 for connecting the venous needle and the arm of the patient. Since the drug solution is injected into the patient's body after being fixed with a bandage or the like, there is a problem that the flow rate of the drug solution is affected by the patient's body temperature. The temperature of the patient's arm depends on the individual difference and the condition of the patient at that time.
In order to manufacture a balloon-in-heater adjusted so that the drug solution is supplied to the patient's body at a desired time since it is different up to ° C, many types of balloon-in-houser are prepared in advance according to the condition. There is a problem to be addressed.

【0006】[0006]

【課題を解決するための手段】本発明者等はこれらの課
題を解決するために鋭意研究した結果、薬液流出アセン
ブリにおける流量制御部を患者の体温の影響を受けない
位置に設置することによって解決することを見出し本発
明に到達した。すなわち、本発明は円筒状外軸と、該外
軸内に内装された内軸と、これらの両軸を被覆するよう
に該両軸の外部に設けられ、その一端が外軸に密着固定
され、他端が内軸に密着固定された弾性材料製バル−ン
と、該バル−ンの内部と連通する薬液の注入と流出を行
うための共通の薬液通路と、該薬液通路の開放側端部に
は嵌合型または螺合型接続具のアダプタ−が形成され、
かつ薬液通路内にはバル−ン内部への薬液注入時にバル
−ン内の薬液が流出するのを阻止し、バル−ンからの薬
液流出時には前記薬液通路の開放側端部から挿入される
連通パイプによって弁の開口可能な逆止弁が設けられて
なるバル−ン部と、チュ−ブ後端には体内に薬液を注入
するための接続具が設けられ、チュ−ブ先端にはバル−
ン内部に連通しうる長さの連通パイプを備えた嵌合また
は螺合可能なコネクタ−が設けられてなる薬液流出アセ
ンブリとからなるバル−ンインヒュ−ザ−において、薬
液量を制御するための流量制御部が連通パイプとチュ−
ブ先端との間、または該チュ−ブの実質的に先端で該チ
ュ−ブ内部に設けられてなるバル−ンインヒュ−ザ−で
ある。また、本発明は前記バル−ンインヒュ−ザ−にお
いて、薬液中の微小物質を除去するためのフイルタ−が
連通パイプと流量制御部の端部との間に設けられてなる
バル−ンインヒュ−ザ−である。更に、本発明は前記バ
ル−ンインヒュ−ザ−において、流量制御部の薬液流量
が少なくとも20ml/時になるように制御されたバル−ン
インヒュ−ザ−である。
The inventors of the present invention have made extensive studies to solve these problems, and as a result, have solved it by installing a flow rate control unit in a drug solution outflow assembly at a position that is not affected by the body temperature of a patient. The present invention has been achieved by finding that That is, according to the present invention, a cylindrical outer shaft, an inner shaft housed in the outer shaft, and an outer shaft of the both shafts are provided so as to cover these both shafts, and one end of the outer shaft is closely fixed to the outer shaft. , A balloon made of an elastic material, the other end of which is closely fixed to the inner shaft, a common chemical liquid passage for injecting and flowing out a chemical liquid which communicates with the inside of the balloon, and an open end of the chemical liquid passage. An adapter of a fitting type or screw type connecting tool is formed in the part,
In addition, when the chemical liquid is injected into the balloon, the chemical liquid is prevented from flowing out into the chemical liquid passage, and when the chemical liquid flows out from the balloon, the communication is inserted from the open end of the chemical liquid passage. A valve part provided with a check valve capable of opening a valve by a pipe, a connector for injecting a drug solution into the body is provided at the rear end of the tube, and a valve is provided at the tip of the tube.
Flow rate for controlling the amount of the chemical liquid in a balloon infusor comprising a chemical liquid outflow assembly provided with a connector that can be fitted or screwed with a communication pipe having a length capable of communicating inside The control unit connects the communication pipe and the
A balloon-in-heater provided inside the tube between the tip of the tube and substantially the tip of the tube. Further, according to the present invention, in the above-mentioned ball-in fuser, a filter for removing minute substances in the chemical liquid is provided between the communication pipe and the end of the flow rate control unit. Is. Further, the present invention is the above-described balloon in- user, in which the flow rate of the chemical liquid in the flow controller is controlled to be at least 20 ml / hour.

【0007】図1は本発明のバル−ンインフュ−ザ−の
一実施例の説明図であって、バル−ン部を薬液流出用ア
センブリ部に接続していない状態を示す説明図、図2は
バル−ンに薬液を充填したときのバル−ン部の拡大断面
図、図3は図1に示す薬液流出用アセンブリ部のコネク
タ−とバル−ン部のルア−テ−パ−状アダプタ−の拡大
断面図、図4は図3に示すコネクタ−をルア−テ−パ−
状アダプタ−に挿入したときの状態を示す説明図、図5
はシリンジ内薬液をバル−ンに注入する際の説明図であ
ってシリンジとバル−ン部が接続していない状態を示す
説明図、図6は図5に示すシリンジから薬液をバル−ン
内へ充填しているときの説明図、図7および図8はバル
−ン内の薬液の排出時間に対する排出量の関係を示す
図、図9および図10は図1の連通パイプを有するコネク
タ−付近の拡大断面図である。
FIG. 1 is an explanatory view of an embodiment of the balloon infuser of the present invention, showing the state in which the balloon portion is not connected to the chemical liquid outflow assembly portion, and FIG. 2 is FIG. 3 is an enlarged cross-sectional view of the balloon portion when the balloon is filled with the chemical liquid. FIG. 3 shows the connector of the chemical liquid outflow assembly portion and the luer taper-shaped adapter of the balloon portion shown in FIG. FIG. 4 is an enlarged cross-sectional view, and FIG. 4 shows the connector shown in FIG.
5 is an explanatory view showing a state in which it is inserted into the linear adapter, FIG.
FIG. 6 is an explanatory view of injecting the drug solution in the syringe into the balloon, and is an explanatory view showing a state in which the syringe and the balloon portion are not connected, and FIG. 6 is a drawing of the drug solution in the balloon from the syringe shown in FIG. 7 and 8 are diagrams showing the relationship between the discharge amount of the chemical liquid in the balloon and the discharge amount, and FIGS. 9 and 10 are the vicinity of the connector having the communication pipe of FIG. FIG.

【0008】図1は本発明のバル−ンインフュ−ザ−の
一実施例の説明図であって、バル−ン部aと薬液流出用
アセンブリ部bとから構成されている。バル−ン部aは
薬液が収容される部分であるとともに、該薬液を人体の
注入箇所へ移動せしめる駆動部分であり、棒状内軸1
と、該内軸1に滑動自在に外装されてなる円筒状外軸2
と、これらの両軸の外部に設けられたバル−ン3と、内
軸1と一体に形成された内軸受け4とで構成されてい
る。外軸2の一端であって、内軸1に外装される側と反
対側の端部には傘状部材5が固着されている。
FIG. 1 is an explanatory view of an embodiment of the balloon infusor of the present invention, which is composed of a balloon portion a and a chemical liquid outflow assembly portion b. The balloon portion a is a portion for accommodating the chemical liquid and a drive portion for moving the chemical liquid to the injection site of the human body, and the rod-shaped inner shaft 1
And a cylindrical outer shaft 2 slidably mounted on the inner shaft 1.
And a balun 3 provided outside of these shafts, and an inner bearing 4 formed integrally with the inner shaft 1. An umbrella-shaped member 5 is fixed to one end of the outer shaft 2 and the end opposite to the side covered by the inner shaft 1.

【0009】バル−ン3は筒状または球状の形状をして
おり、内軸1および外軸2を被覆するようにこれら両軸
の外部に設けられており、その一端は内軸1に、他端は
外軸2にO−リングなどのシ−ル手段6によって気密に
密着固定されている。バル−ン3は、患者への薬液注入
量、注入時間などに応じて種々の大きさ、肉厚のものを
用いることができ、本発明においては特に限定されるも
のでない。バル−ン3は薬液を充填することによって膨
張し、長方形状のバル−ンでは半径方向とともに長手方
向にも膨張しうる構造になっている。
The balloon 3 has a cylindrical or spherical shape and is provided outside the inner shaft 1 and the outer shaft 2 so as to cover the inner shaft 1 and the outer shaft 2. One end of the ball 3 is attached to the inner shaft 1. The other end is hermetically fixed to the outer shaft 2 by a seal means 6 such as an O-ring. As the balloon 3, various sizes and wall thicknesses can be used according to the amount of drug solution to be injected into the patient, the injection time, etc., and the present invention is not particularly limited. The balloon 3 expands when filled with a chemical solution, and the rectangular balloon has a structure capable of expanding not only in the radial direction but also in the longitudinal direction.

【0010】外軸2はバル−ン3の動きに付随して内軸
1をガイドとして軸方向に移動し、その位置とバル−ン
3内に残っている薬液の量との関係は一定であるので内
軸1またはハウジング7に目盛りを設けることで薬液の
流出量を確認することができる。外軸2の一端であっ
て、内軸1に外装されている側と反対側の端部には、耐
水圧フイルタ−8が設けられている。この耐水圧フイル
タ−8は薬液注入時にバル−ン3内に残存している空気
を外部に追い出す役割を果たす部材であり、ポリエステ
ル、弗素樹脂またはこれらをラミネ−トしたものなどで
作製することができる。
The outer shaft 2 moves in the axial direction with the inner shaft 1 as a guide in association with the movement of the balloon 3, and the relationship between the position and the amount of the chemical liquid remaining in the balloon 3 is constant. Therefore, by providing a scale on the inner shaft 1 or the housing 7, the outflow amount of the chemical liquid can be confirmed. A water pressure resistant filter 8 is provided at one end of the outer shaft 2 and at the end opposite to the side covered by the inner shaft 1. The water pressure resistant filter 8 is a member which plays a role of expelling the air remaining in the balloon 3 to the outside at the time of injecting the chemical liquid, and may be made of polyester, fluororesin or a laminate of these. it can.

【0011】バル−ン3は弾性材料からなり、その材料
としてはシリコ−ンゴム、ブチルゴム、ニトリルブタジ
ェンゴム、ポリ-1,4−ブタジェン、ポリイソプレン、ポ
リウレタン、ブタジェンスチレン共重合体、ポリスチレ
ンポリブタジエンブロック共重合体の水素添加物質など
の弾性重合体または天然ゴム、これらの重合体混合物、
またはこれらの物質の添加剤を除去したのち人体に無害
の酸化防止剤を添加した加工物質、またはラミネ−ト等
が挙げられる。
Balloon 3 is made of an elastic material, and its material is silicone rubber, butyl rubber, nitrile butadiene rubber, poly-1,4-butadiene, polyisoprene, polyurethane, butadiene styrene copolymer, polystyrene polybutadiene. Elastic polymers or natural rubbers such as hydrogenated substances of block copolymers, mixtures of these polymers,
Alternatively, a processed substance obtained by removing an additive of these substances and then adding a harmless antioxidant to a human body, a laminate or the like can be mentioned.

【0012】内軸1の一端であって、外軸2が外装され
る側と反対側の端部には、内軸受け4が該内軸1と一体
に形成されている。該内軸受け4は短円筒状部材であ
り、その内軸1側端部には薬液流出入口が形成されてい
る。薬液流出入口は内軸受け4内部を介してハウジング
7の薬液通路と連通している。ハウジング7はバル−ン
3が外部の鋭利な物体に触れて破損するのを防止すると
ともに、バル−ン自体のピンホ−ルなどの欠陥によって
バル−ン3から液洩れが発生した場合に外部に薬液が飛
散しないように薬液を密封する機能を果たす部分であ
る。ハウジング7の適宜の箇所には空気抜きの開口部10
が形成されており、該開口部10に空気は通過させるが薬
液は通過させない疎水性フイルタ−11を設けるのが好ま
しい。
An inner bearing 4 is formed integrally with the inner shaft 1 at one end of the inner shaft 1 opposite to the outer shaft 2 exterior side. The inner bearing 4 is a short cylindrical member, and a chemical solution inflow / outflow port is formed at an end portion on the inner shaft 1 side. The chemical solution outflow port communicates with the chemical solution passage of the housing 7 through the inside of the inner bearing 4. The housing 7 prevents the ball 3 from being damaged by touching an external sharp object, and when the liquid leaks from the ball 3 due to a defect such as a pinhole of the ball itself, the housing 7 is exposed to the outside. It is a part that functions to seal the chemical liquid so that the chemical liquid does not scatter. An air vent opening 10 is provided at an appropriate location on the housing 7.
It is preferable that the opening 10 is provided with a hydrophobic filter 11 through which air can pass but a drug solution cannot pass.

【0013】ハウジング7の一端面はキャップ12により
閉じられており、該キャップ12の中央部分には薬液をバ
ル−ン3内に注入したり、該バル−ン3より薬液を所定
箇所に注入する際に薬液の流路となる薬液通路13が形成
されている。薬液通路13には、図2〜図4に示されるよ
うにバル−ン3側からダックビルタイプの逆止弁14、固
定デイスク15およびシ−ル手段16が設けられている。ダ
ックビルタイプの逆止弁14は弁の閉鎖端がカモノハシの
嘴のような尖った形状をしており、バル−ン3内部への
薬液の流通は許すが、その逆方向の流れは阻止する構造
となっている。逆止弁14としては、前記ダックビルタイ
プの弁のほかにも傘弁、フラップ弁、ポペット弁、ボ−
ル弁などを用いることができ、これらの弁材料としては
弗素樹脂、ナイロン、ポリオレフイン、ポリ塩化ビニ
ル、ポリカ−ボネ−ト、シリコ−ン樹脂などが挙げられ
る。固定デイスク15は逆止弁14の基板を支持するもので
あり、中央部には薬液の流出流入のための開口部17が形
成されている。
One end surface of the housing 7 is closed by a cap 12, and the central part of the cap 12 is filled with a chemical solution into the balloon 3 or is injected from the ball 3 into a predetermined location. At this time, a chemical liquid passage 13 is formed which serves as a flow path for the chemical liquid. As shown in FIGS. 2 to 4, a duckbill type check valve 14, a fixed disk 15 and a seal means 16 are provided in the chemical liquid passage 13 from the side of the balloon 3. The duckbill type check valve 14 has a structure in which the closed end of the valve has a sharp shape like a duckbill's beak, and allows the chemical liquid to flow into the balloon 3, but prevents the flow in the opposite direction. Has become. As the check valve 14, in addition to the duck bill type valve, an umbrella valve, a flap valve, a poppet valve, and a baud valve.
For example, a fluorine valve, nylon, polyolefin, polyvinyl chloride, polycarbonate, silicone resin or the like can be used as the valve material. The fixed disk 15 supports the substrate of the check valve 14, and has an opening 17 formed at the center for inflow and outflow of the chemical solution.

【0014】接続具であるロックアダプタ−19と固定デ
イスク15により形成された環状凹所18内には、シ−ル手
段16たるO−リングが配設されている。このO−リング
の内径は連通パイプの外径と同一もしくはそれより小さ
く、これによって連通パイプを薬液通路13内に挿入した
ときのシ−ル性が高められるようになっている。ロック
アダプタ−19は内面がルア−テ−パ−状に形成されたほ
ぼ円筒状の接続具である。このロックアダプタ−19はキ
ャップ12に形成された凹所20内に嵌め込まれている。ロ
ックアダプタ−19の端部外周には薬液流出アセンブリb
を接続するためのネジ部21が形成されている。
An O-ring as a sealing means 16 is disposed in an annular recess 18 formed by a lock adapter 19 which is a connecting tool and a fixed disk 15. The inner diameter of the O-ring is the same as or smaller than the outer diameter of the communication pipe, so that the sealing property when the communication pipe is inserted into the chemical liquid passage 13 is enhanced. The lock adapter 19 is a substantially cylindrical connector having an inner surface formed in a luer taper shape. The lock adapter 19 is fitted in a recess 20 formed in the cap 12. The chemical solution outflow assembly b is provided on the outer periphery of the end of the lock adapter-19.
Is formed with a screw portion 21 for connecting.

【0015】薬液流出アセンブリbはロックアダプタ−
19に接続される接続具であるコネクタ−部30と、薬液量
を制御するための流量制御部31と、薬液注入チュ−ブ32
と、接続具33とで構成されている。コネクタ−部30の一
端にはロックアダプタ−19に接続されたときに、逆止弁
14を押し開いてバル−ン3内部に連通しうる長さを有す
る連通パイプ34が設けられている。この連通パイプ34は
ポリカ−ボネ−ト、ポリ塩化ビニル、ポリオレフインな
どの合成樹脂やステンレスなどの金属で作製することが
できる。連通パイプ34はコネクタ−部30の内周面に固着
されている。連通パイプ34の突出長さLは、図4に示さ
れるようにコネクタ−部30とロックアダプタ−19が接続
されたときにダックビルタイプの逆止弁14を押し広げう
る長さに設定されている。これにより逆止弁14の逆止効
果が強制的に解除されて、注入針を用いなくともバル−
ン3 内に充填された薬液の流出が可能になる。コネクタ
−部側のネジ部35はロクアダプタ−19に形成されたネジ
部21との螺合によりバル−ン部aと薬液流出アセンブリ
bとの接続が行われる。この接続は螺合以外に嵌合で行
うようにしてもよい。
The chemical liquid outflow assembly b is a lock adapter-
A connector part 30 which is a connecting tool to be connected to 19, a flow rate control part 31 for controlling the amount of chemical liquid, and a chemical liquid injection tube 32.
And a connector 33. One end of the connector part 30 has a check valve when connected to the lock adapter-19.
A communication pipe 34 having a length capable of pushing and opening 14 to communicate with the inside of the balloon 3 is provided. The communication pipe 34 can be made of a synthetic resin such as polycarbonate, polyvinyl chloride, or polyolefin, or a metal such as stainless steel. The communication pipe 34 is fixed to the inner peripheral surface of the connector portion 30. As shown in FIG. 4, the protruding length L of the communication pipe 34 is set to such a length that the duckbill type check valve 14 can be expanded when the connector portion 30 and the lock adapter 19 are connected. .. As a result, the non-return effect of the check valve 14 is forcibly released, and the valve can be removed without using the injection needle.
The chemical liquid filled in the inlet 3 can be discharged. The screw portion 35 on the connector portion side is screwed with the screw portion 21 formed on the lock adapter 19 to connect the balloon portion a and the chemical liquid outflow assembly b. This connection may be made by fitting instead of screwing.

【0016】流量制御部31は薬液の流量を制御する部分
であり、本出願人が既に出願した特開平1-135356号、特
開平2-11160号あるいは特開平3-140163号で提案した
下流側先端の閉塞されたパイプであって少なくとも1個
の微細孔を有するパイプ、多孔質ガラスパイプなどの
有孔パイプ、内径が小径のステンレスパイプ、合成樹
脂製パイプなどを用いることができる。流量制御部31は
チュ−ブ32の先端40と連通パイプ34との間、または該チ
ュ−ブ32の実質的に先端40で該チュ−ブ32の内部に設け
られる。流量制御部31はチュ−ブ32の先端40と連通パイ
プ34との間に設けられる場合には、たとえば流量制御部
31とチュ−ブ32とコネクタ−30は図9に示すように、流
量制御部31およびチュ−ブ32の外径より大きい内径を有
する外套部41で流量制御部31、チュ−ブ32およびコネク
タ−30を熱溶着して成形することができる。この場合に
は、流量制御部31は内径が小径の合成樹脂製パイプが好
ましい。また、流量制御部31は図10に示すようなチュ−
ブ32の実質的に先端40で該チュ−ブ32の内部にに設けて
もよい。この場合にはチュ−ブ32の先端40はコネクタ−
30の内部に熱溶着して成形することもできる。流量制御
部31の薬液流量は少なくとも20ml/時になるように制御
されるのが好ましい。薬液流量が20ml/時未満である
と、薬液流出アセンブリb内の空気抜きに時間を要する
傾向があるので好ましくない。
The flow rate control section 31 is a section for controlling the flow rate of the chemical liquid, and is located on the downstream side as proposed in Japanese Patent Application Laid-Open No. 1-135356, Japanese Patent Application Laid-Open No. 2-11160 or Japanese Patent Application Laid-Open No. 3-140163. It is possible to use a pipe having a closed tip and having at least one fine hole, a perforated pipe such as a porous glass pipe, a stainless pipe having a small inner diameter, and a synthetic resin pipe. The flow rate control unit 31 is provided inside the tube 32 between the tip 40 of the tube 32 and the communication pipe 34 or substantially at the tip 40 of the tube 32. When the flow rate control unit 31 is provided between the tip 40 of the tube 32 and the communication pipe 34, for example, the flow rate control unit
As shown in FIG. 9, the reference numeral 31, the tube 32, and the connector 30 are a flow control section 31, a tube 32, and a connector having an outer jacket 41 having an inner diameter larger than the outer diameter of the tube 32. -30 can be heat-welded and molded. In this case, the flow rate control unit 31 is preferably a synthetic resin pipe having a small inner diameter. In addition, the flow rate control unit 31 includes a tube as shown in FIG.
It may be provided inside the tube 32 substantially at the tip 40 of the tube 32. In this case, the tip 40 of the tube 32 is the connector-
It can also be heat-welded and molded into the inside of 30. The flow rate of the chemical solution in the flow rate control unit 31 is preferably controlled to be at least 20 ml / hour. A flow rate of the chemical liquid of less than 20 ml / hour is not preferable because it tends to take time to remove air from the chemical liquid outflow assembly b.

【0017】連通パイプ34と流量制御部31との間には、
バル−ン3内の薬液に含有されている微小物質を除去す
るためのフイルタ−42が設けられていてもよい。フイル
タ−42としては繊維状物、焼結物等が使用される。チュ
−ブ32は軟質ポリ塩化ビニル、ポリプロピレン、ポリエ
ステルなどからなり、その他端にはルア−テ−パ−状の
接続具33が設けられ、接続具33を介して静脈針やPSV
セットなどが接続される。接続具33には静脈圧などによ
り薬液が逆流するのを防止するための逆止弁(図示せ
ず)を装備してもよい。
Between the communication pipe 34 and the flow rate control unit 31,
A filter 42 for removing minute substances contained in the chemical liquid in the balloon 3 may be provided. As the filter 42, a fibrous material, a sintered material or the like is used. The tube 32 is made of soft polyvinyl chloride, polypropylene, polyester or the like, and has a luer taper-like connecting member 33 provided at the other end thereof, through which the venous needle or PSV is connected.
Sets etc. are connected. The connection tool 33 may be equipped with a check valve (not shown) for preventing backflow of the drug solution due to venous pressure or the like.

【0018】次に、本発明のバル−ンインフュ−ザ−の
使用方法の一例について説明する。薬液のバル−ンへの
注入は、図5および図6に示すように薬液通路内に注射
器のシリンジを挿入し、このシリンジをロックアダプタ
−19のルア−テ−パ−状の内周面に押しつけるようにし
て行われる。このときシリンジ22の針基先端は逆止弁14
の入口側にある。挿入部は注入口が広くなった分だけ、
従来の注射針による場合に比較して充填圧が小さくな
り、注入が容易になるとともに短時間で注入操作を終了
させることができる。
Next, an example of a method of using the balloon infuser of the present invention will be described. To inject the drug solution into the balloon, insert a syringe of a syringe into the drug solution passage as shown in FIGS. 5 and 6, and attach the syringe to the inner surface of the lock adapter 19 in the luer taper shape. It is done by pressing. At this time, the needle base tip of the syringe 22 has a check valve 14
On the entrance side of. The insertion part is wide because the inlet is wide,
The filling pressure becomes smaller as compared with the case of using a conventional injection needle, the injection is facilitated, and the injection operation can be completed in a short time.

【0019】薬液を充填するにつれて、バル−ン3は膨
張する。この際、バル−ン3内に残存している内部空気
は耐水圧フイルタ−8を通って外部に追い出される。ま
た、バル−ン3の拡張とともに内軸1に外装されている
外軸2は長手方向にスライドし、ハウジング7面に沿っ
て進んでいく。所定量の薬液充填が終わると注射器をロ
ックアダプタ−19から抜き取る。薬液充填完了時には、
傘状部材5とハウジング7の端部内面とが合致し、バル
−ン3膨張時の曲がりと振動によるバル−ンの破裂が防
止される。次に図4に示されるように薬液流出アセンブ
リ部bのコネクタ−部30とロックアダプタ−19内とを接
続する。この際、コネクタ−部30の連通パイプ34は逆止
弁14を押し広げて、バル−ン3内部と連通パイプ34とが
連通状態になる。その後は接続具33を介してPSVセッ
トなどに接続し空気抜きなどの所定の操作を行った後
に、バル−ン3内の薬液は流量制御部31によって流量を
制御されながら患者の体内に薬液の注入が行われる。
The balloon 3 expands as the chemical is filled. At this time, the internal air remaining in the balloon 3 is expelled to the outside through the water pressure resistant filter 8. Further, as the balloon 3 expands, the outer shaft 2 which is externally mounted on the inner shaft 1 slides in the longitudinal direction and advances along the surface of the housing 7. When the prescribed amount of drug solution is filled, the syringe is pulled out from the lock adapter-19. When the liquid filling is completed,
The umbrella-shaped member 5 and the inner surface of the end portion of the housing 7 are aligned with each other, and the balloon is prevented from bursting due to bending and vibration when the balloon 3 expands. Next, as shown in FIG. 4, the connector portion 30 of the chemical liquid outflow assembly portion b and the inside of the lock adapter-19 are connected. At this time, the communication pipe 34 of the connector portion 30 pushes the check valve 14 wide so that the interior of the balloon 3 and the communication pipe 34 are in communication with each other. After that, after connecting to a PSV set or the like via a connecting tool 33 and performing a predetermined operation such as air bleeding, the drug solution in the balloon 3 is injected into the patient's body while the flow rate is controlled by the flow rate control unit 31. Is done.

【0020】[0020]

【作用】本発明は薬液をバル−ン内に充填して膨張した
バル−ンの収縮力を利用して、バル−ン内の薬液を患者
に注入するものである。バル−ン内の薬液の流出速度を
制御する流量制御部は薬液注入チュ−ブの先端側でハウ
ジングに近接して設けられているので、被服のポケット
等の袋内に薬液入りバル−ンを含有したハウジングとと
もに収納される。その結果、流量制御部は身体に密着し
ないので体温の影響を受けないで所望する流速でバル−
ン内の薬液を流出することができる。また、本発明のバ
ル−ン内の薬液は内軸の端部から流出する構造になって
いるので従来のバル−ンインヒュ−ザ−の外軸端部から
薬液を流出させるものと比較してバル−ン内の薬液の残
液が少ない。更に、バル−ン部と薬液流出用アセンブリ
との接続はバル−ン部に設けた逆止弁を介して嵌合また
は螺合しているので、従来の栓体に注射針を突き刺して
薬液をバル−ンに注入する場合と比較して充填圧が小さ
く薬液の注入が容易であり、また注射針近辺からバル−
ン内の薬液が洩れることもない。
The present invention is to inject the drug solution in the balloon into the patient by utilizing the contracting force of the balloon which is filled with the drug solution and expanded. Since the flow rate control unit that controls the outflow rate of the drug solution in the balloon is provided close to the housing on the tip side of the drug solution injection tube, the balloon containing the drug solution in a bag such as a pocket of clothing is not provided. It is stored with the housing that contains it. As a result, the flow rate controller does not come into close contact with the body, so the flow rate is not affected by the body temperature and the flow rate is desired at the desired flow rate.
The drug solution in the tank can be drained. Further, since the chemical liquid in the balloon of the present invention is structured to flow out from the end portion of the inner shaft, compared with the conventional balloon infusor in which the chemical liquid flows out from the end portion of the outer shaft, -There is not much liquid remaining in the container. Furthermore, since the connection between the balloon part and the drug solution outflow assembly is fitted or screwed through the check valve provided in the balloon part, the conventional stopper is pierced with the injection needle to allow the drug solution to be injected. Compared with the case of injecting into a balloon, the filling pressure is small and it is easy to inject the drug solution.
There is no leakage of the drug solution inside.

【0021】[0021]

【実施例】以下実施例で本発明の一例を説明する。EXAMPLES An example of the present invention will be described below with reference to examples.

【実施例1】加硫された天然ゴム製管状体(小峰ゴム社
製)をアセトン・ヘキサン混合溶剤(混合容積比1:
2)でソックスレ−抽出を3時間行い、天然ゴム製管状
体中の添加剤を抽出除去した。次いで該管状体を1,
3,5−トリメチル−2,4,6−トリス(3,5−ジ
−t−ブチル−4−ヒドロキシベンジル)ベンゼン(以
下BHTという)をアセトン・ヘキサン混合溶剤(混合
容積比1:2)の溶液(濃度0.01g/ml)中に25℃の温度
で24時間浸漬し、該管状体中に酸化防止剤であるBHT
を含浸させた。その後管状体をエタノ−ルで洗浄し25℃
の温度で12時間乾燥させた。この処理済天然ゴム製管状
体を図1に示すバル−ンインフュ−ザ−に組み込み、10
0ml の水をバル−ン内に充填した。次いで極細のポリ塩
化ビニル製パイプ(外径 0.3mm、内径 0.114mm、長さ20
mm)からなる流量制御部を図9のように取りつけ、バル
−ン内の水を接続具に取りつけた静脈針から滴下した。
この時のバル−ン内の水の排出時間に対する排出量の関
係を図7に示す。
Example 1 A vulcanized natural rubber tubular body (made by Komine Rubber Co., Ltd.) was mixed with an acetone / hexane mixed solvent (mixing volume ratio 1:
Soxhlet extraction was carried out for 3 hours in 2), and the additives in the natural rubber tubular body were extracted and removed. Then the tubular body
3,5-Trimethyl-2,4,6-tris (3,5-di-t-butyl-4-hydroxybenzyl) benzene (hereinafter referred to as BHT) was mixed with acetone / hexane mixed solvent (mixing volume ratio 1: 2). BHT which is an antioxidant is immersed in the solution (concentration 0.01 g / ml) at a temperature of 25 ° C. for 24 hours,
Was impregnated. After that, the tubular body was washed with ethanol and washed at 25 ° C.
It was dried at a temperature of 12 hours. This treated natural rubber tubular body was incorporated into the balloon infuser shown in FIG.
0 ml of water was charged into the balloon. Next, extra-fine polyvinyl chloride pipe (outer diameter 0.3 mm, inner diameter 0.114 mm, length 20
mm) was attached as shown in FIG. 9, and the water in the balloon was dropped from the venous needle attached to the connector.
FIG. 7 shows the relationship between the discharge time of water in the balloon and the discharge amount at this time.

【0022】[0022]

【実施例2】実施例1で得た処理済天然ゴム製管状体を
図1に示すバル−ンインフュ−ザ−に組み込み、100ml
の水をバル−ン内に充填した。次いで極細のポリ塩化ビ
ニル製パイプ(外径 0.3mm、内径 0.13mm、長さ20mm)
からなる流量制御部を図10のように取りつけ、バル−ン
内の水を接続具に取りつけた静脈針から滴下した。この
時のバル−ン内の水の排出時間に対する排出量の関係を
図8に示す。図7および図8から明らかなように、バル
−ン内の水はほぼ一定の流速で滴下された。
Example 2 The treated natural rubber tubular body obtained in Example 1 was incorporated into a balloon infuser shown in FIG.
Of water was charged into the balloon. Next, extra-fine polyvinyl chloride pipe (outer diameter 0.3 mm, inner diameter 0.13 mm, length 20 mm)
As shown in FIG. 10, the flow rate control unit consisting of was attached, and the water in the balloon was dropped from the vein needle attached to the connector. FIG. 8 shows the relationship between the discharge time of water in the balloon and the discharge amount at this time. As is clear from FIGS. 7 and 8, the water in the balloon was dropped at a substantially constant flow rate.

【0023】[0023]

【発明の効果】本発明はバル−ン内の薬液の流出速度を
制御する流量制御部が薬液注入チュ−ブの先端側でハウ
ジングに近接して設けられているので、流量制御部は被
服の袋内に薬液入りバル−ンを含有したハウジングとと
もに収納される。そのために流量制御部は身体に密着せ
ず、個人差や健康状態によって異なる体温の影響を受け
ないで所望する流速でバル−ン内の薬液を流出すること
ができる。その結果、バル−ンインヒュ−ザ−は品種を
少なくして製造することができるようになった。また、
本発明のバル−ン内の薬液は内軸の端部から流出する構
造になっているので、バル−ン内の薬液を流出させた後
の残液量が少なく、高価な薬品を使用する場合には経済
的効果を有する。更に、バル−ン部と薬液流出用アセン
ブリとの接続はバル−ン部に逆止弁を設けて嵌合または
螺合しているので、従来の栓体に注射針を突き刺して薬
液をバル−ンに注入する場合と比較して充填圧が小さく
薬液の注入が容易であり、また注射針近辺からバル−ン
内の薬液が洩れることもない。
According to the present invention, since the flow rate control unit for controlling the outflow rate of the drug solution in the balloon is provided close to the housing on the tip side of the drug solution injection tube, the flow rate control unit can be used for clothing. It is housed in a bag together with a housing containing a balloon containing a chemical solution. Therefore, the flow rate control unit does not come into close contact with the body, and the drug solution in the balloon can flow out at a desired flow rate without being affected by the body temperature that varies depending on individual differences and health conditions. As a result, it has become possible to manufacture the balloon inusers with a reduced variety. Also,
Since the chemical liquid in the balloon of the present invention is structured to flow out from the end portion of the inner shaft, the residual liquid amount after the chemical liquid in the balloon is discharged is small, and when an expensive chemical is used. Has an economic effect on. Further, since the check valve is provided in the balloon part to fit or screw the balloon part and the drug solution outflow assembly, the conventional stopper is pierced with the injection needle to allow the drug solution to flow. As compared with the case of injecting into the balloon, the filling pressure is small and the injection of the drug solution is easy, and the drug solution in the balloon does not leak from the vicinity of the injection needle.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明のバル−ンインフュ−ザ−の一実施例の
説明図であって、バル−ン部を薬液流出用アセンブリ部
に接続していない状態を示す説明図。
FIG. 1 is an explanatory view of an embodiment of a balloon infusor of the present invention, showing a state in which the balloon portion is not connected to a chemical liquid outflow assembly portion.

【図2】バル−ンに薬液を充填したときのバル−ン部の
拡大断面図。
FIG. 2 is an enlarged cross-sectional view of a balloon portion when the balloon is filled with a chemical solution.

【図3】図1に示す薬液流出用アセンブリ部のコネクタ
−とバル−ン部のルア−テ−パ−状アダプタ−の拡大断
面図。
FIG. 3 is an enlarged cross-sectional view of the connector of the chemical liquid outflow assembly portion and the luer taper-shaped adapter of the balloon portion shown in FIG.

【図4】図3に示すコネクタ−をルア−テ−パ−状アダ
プタ−に挿入したときの状態を示す説明図。
FIG. 4 is an explanatory view showing a state when the connector shown in FIG. 3 is inserted into a luer taper-shaped adapter.

【図5】シリンジ内薬液をバル−ンに注入する際の説明
図であってシリンジとバル−ン体が接続していない状態
を示す説明図。
FIG. 5 is an explanatory diagram when injecting the drug solution in the syringe into the balloon, and is an explanatory diagram showing a state in which the syringe and the balloon body are not connected.

【図6】図5に示すシリンジから薬液をバル−ン内へ充
填しているときの説明図。
FIG. 6 is an explanatory view when the drug solution is filled into the balloon from the syringe shown in FIG.

【図7】バル−ン内の薬液の排出時間に対する排出量の
関係を示す図。
FIG. 7 is a diagram showing the relationship between the discharge time and the discharge amount of the chemical liquid in the balloon.

【図8】バル−ン内の薬液の排出時間に対する排出量の
関係を示す図。
FIG. 8 is a diagram showing the relationship between the discharge time and the discharge amount of the chemical liquid in the balloon.

【図9】図1の連通パイプを有するコネクタ−付近の拡
大断面図
9 is an enlarged cross-sectional view of the vicinity of the connector having the communication pipe of FIG.

【図10】図1の連通パイプを有するコネクタ−付近の拡
大断面図
10 is an enlarged cross-sectional view of the vicinity of the connector having the communication pipe of FIG.

【図11】特願平第2−216621号のバル−ンインヒュ−ザ
−の全体説明図であって、連通パイプがハウジングの接
続具に嵌合または螺合していない状態を示す。
FIG. 11 is an overall explanatory view of the balloon in-user of Japanese Patent Application No. 2-216621, showing a state where the communication pipe is not fitted or screwed into the connector of the housing.

【図12】図11に示すバル−ンに薬液を充填した時の状態
を示す拡大断面図。
12 is an enlarged cross-sectional view showing a state when the balloon shown in FIG. 11 is filled with a chemical liquid.

【符号の説明】[Explanation of symbols]

a バル−ン部 b 薬液流出用アセンブリ部 1 内軸 2 外軸 3 バル−ン 7 ハウジング 14 逆止弁 19 ロックアダプタ− 30 コネクタ−部 31 流量制御部 32 チュ−ブ 34 連通パイプ a Balloon part b Chemical liquid outflow assembly part 1 Inner shaft 2 Outer shaft 3 Balloon 7 Housing 14 Check valve 19 Lock adapter-30 Connector part 31 Flow control part 32 Tube 34 Communication pipe

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 円筒状外軸と、該外軸内に内装された内
軸と、これらの両軸を被覆するように該両軸の外部に設
けられ、その一端が外軸に密着固定され、他端が内軸に
密着固定された弾性材料製バル−ンと、該バル−ンの内
部と連通する薬液の注入と流出を行うための共通の薬液
通路と、該薬液通路の開放側端部には嵌合型または螺合
型接続具のアダプタ−が形成され、かつ薬液通路内には
バル−ン内部への薬液注入時にバル−ン内の薬液が流出
するのを阻止し、バル−ンからの薬液流出時には前記薬
液通路の開放側端部から挿入される連通パイプによって
弁の開口可能な逆止弁が設けられてなるバル−ン部と、
チュ−ブ後端には体内に薬液を注入するための接続具が
設けられ、チュ−ブ先端にはバル−ン内部に連通しうる
長さの連通パイプを備えた嵌合または螺合可能なコネク
タ−が設けられてなる薬液流出アセンブリとからなるバ
ル−ンインヒュ−ザ−において、薬液量を制御するため
の流量制御部が連通パイプとチュ−ブ先端との間、また
は該チュ−ブの実質的に先端で該チュ−ブ内部に設けら
れてなるバル−ンインヒュ−ザ−。
1. A cylindrical outer shaft, an inner shaft housed inside the outer shaft, and an outer shaft provided so as to cover both shafts, one end of which is closely attached to the outer shaft. , A balloon made of an elastic material, the other end of which is closely fixed to the inner shaft, a common chemical liquid passage for injecting and flowing out a chemical liquid which communicates with the inside of the balloon, and an open end of the chemical liquid passage. An adapter of a fitting type or screw type connecting tool is formed in the portion, and the chemical liquid in the chemical liquid passage is prevented from flowing out during injection of the chemical liquid into the balloon, A valve portion provided with a check valve capable of opening the valve by a communication pipe inserted from the open end of the liquid medicine passage when the liquid medicine flows out of the valve,
A connection tool for injecting a medicinal solution into the body is provided at the rear end of the tube, and a fitting pipe having a length of communication pipe that can communicate with the inside of the balloon is provided at the tip of the tube and can be fitted or screwed. In a balun-in-user comprising a chemical liquid outflow assembly provided with a connector, a flow rate control unit for controlling the chemical liquid amount is provided between the communication pipe and the tip of the tube or a substantial part of the tube. A ball-in fuser having a distal end provided inside the tube.
【請求項2】 薬液中の微小物質を除去するためのフイ
ルタ−が連通パイプと流量制御部の端部との間に設けら
れてなる請求項1記載のバル−ンインヒュ−ザ−。
2. The balloon inuser according to claim 1, wherein a filter for removing minute substances in the chemical liquid is provided between the communication pipe and the end of the flow rate control unit.
【請求項3】 流量制御部の薬液流量が少なくとも20ml
/時になるように制御された請求項1または2記載のバ
ル−ンインヒュ−ザ−。
3. The flow rate of the chemical liquid in the flow rate control unit is at least 20 ml.
3. The balloon injector according to claim 1 or 2, which is controlled so as to be / hour.
JP03328102A 1991-11-15 1991-11-15 Balloon Infuser Expired - Fee Related JP3109192B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03328102A JP3109192B2 (en) 1991-11-15 1991-11-15 Balloon Infuser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03328102A JP3109192B2 (en) 1991-11-15 1991-11-15 Balloon Infuser

Publications (2)

Publication Number Publication Date
JPH05137785A true JPH05137785A (en) 1993-06-01
JP3109192B2 JP3109192B2 (en) 2000-11-13

Family

ID=18206531

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03328102A Expired - Fee Related JP3109192B2 (en) 1991-11-15 1991-11-15 Balloon Infuser

Country Status (1)

Country Link
JP (1) JP3109192B2 (en)

Also Published As

Publication number Publication date
JP3109192B2 (en) 2000-11-13

Similar Documents

Publication Publication Date Title
KR960012362B1 (en) Liquid infusion device
US4318400A (en) Medical infusor
US4813937A (en) Ambulatory disposable infusion delivery system
US5178610A (en) Liquid infusion device
EP0427852A1 (en) Balloon-carrying instrument for use in continuously injecting medical fluid
KR970005840B1 (en) Continuous drug solution injector equipped with balloon
US6245041B1 (en) Fluid dispenser with fill adapter
JPH0871162A (en) Medicinal liquid injecting appliance
JPH042360A (en) Balloon infuser
JP3102173B2 (en) Chemical injection device
JP3109192B2 (en) Balloon Infuser
JP2586275B2 (en) Chemical injection tool
JP3586964B2 (en) Continuous injector
JPH10113385A (en) Liquid medicine continuous injection device
JPH0687898B2 (en) Balloon infusor
JP3120922B2 (en) Chemical injection device
JP3087266B2 (en) Chemical injection device
JP2637579B2 (en) Balloon infuser
JP2598529B2 (en) Balloon infuser
JPH0683725B2 (en) Balloon body for injecting drug solution and drug injection tool using the same
JP3203622B2 (en) Balloon infuser
KR200219718Y1 (en) fluid transfusion injection equipment of medical air valve
JPH0775674A (en) Liquid chemical injecting appliance
JPH0687896B2 (en) Balloon infusor
EP0245056A1 (en) Ambulatory disposable infusion pump

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100914

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110914

Year of fee payment: 11

LAPS Cancellation because of no payment of annual fees